Literature DB >> 22303524

The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles.

Rajamannar Ramasubbu1, Serge Beaulieu, Valerie H Taylor, Ayal Schaffer, Roger S McIntyre.   

Abstract

BACKGROUND: Medical comorbidity is commonly encountered in individuals with major depressive disorder (MDD) and bipolar disorder (BD). The presence of medical comorbidity has diagnostic, prognostic, treatment, and etiologic implications underscoring the importance of timely detection and treatment.
METHODS: A selective review of relevant articles and reviews published in English-language databases (1968 to April 2011) was conducted. Studies describing epidemiology, temporality of onset, treatment implications, and prognosis were selected for review.
RESULTS: A growing body of evidence from epidemiologic, clinical, and biologic studies suggests that the relationship between medical illness and mood disorder is bidirectional in nature. It provides support for the multiplay of shared and specific etiologic factors interlinking these conditions.
CONCLUSIONS: This article describes the complex interactions between medical illness and mood disorders and provides a meaningful approach to their comorbid clinical diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22303524

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  20 in total

1.  Healthcare costs in chronically ill community-living older adults are dependent on mental disorders.

Authors:  Helen-Maria Vasiliadis; Samantha Gontijo Guerra; Veronica Chudzinski; Michel Préville
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

Review 2.  Integrating bipolar disorder management in primary care.

Authors:  Amy M Kilbourne; David E Goodrich; Allison N O'Donnell; Christopher J Miller
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Authors:  Sidney H Kennedy; Raymond W Lam; Roger S McIntyre; S Valérie Tourjman; Venkat Bhat; Pierre Blier; Mehrul Hasnain; Fabrice Jollant; Anthony J Levitt; Glenda M MacQueen; Shane J McInerney; Diane McIntosh; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Norma L Pearson; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Authors:  Sagar V Parikh; Lena C Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

5.  Bridging the mental-physical divide in health care.

Authors:  Mark Sinyor; Benjamin I Goldstein; Ayal Schaffer
Journal:  CMAJ       Date:  2019-07-02       Impact factor: 8.262

6.  Depression in Diabetic Patients: What Is the Link With Eating Disorders? Results of a Study in a Representative Sample of Patients With Type 1 Diabetes.

Authors:  Federica Pinna; Federico Suprani; Valeria Deiana; Lorena Lai; Mirko Manchia; Pasquale Paribello; Giulia Somaini; Enrica Diana; Eraldo Francesco Nicotra; Fernando Farci; Mariangela Ghiani; Rossella Cau; Marta Tuveri; Efisio Cossu; Elena Loy; Andrea Crapanzano; Paola Grassi; Andrea Loviselli; Fernanda Velluzzi; Bernardo Carpiniello
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

Review 7.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

8.  Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.

Authors:  Emma Morton; Venkat Bhat; Peter Giacobbe; Wendy Lou; Erin E Michalak; Shane McInerney; Trisha Chakrabarty; Benicio N Frey; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  CNS Drugs       Date:  2021-04-16       Impact factor: 5.749

9.  The association between mood and anxiety disorders, and coronary heart disease in Brazil: a cross-sectional analysis on the Brazilian longitudinal study of adult health (ELSA-Brasil).

Authors:  Andrew H Kemp; Andre R Brunoni; Maria A Nunes; Itamar S Santos; Alessandra C Goulart; Antonio L Ribeiro; Isabela M Benseñor; Paulo A Lotufo
Journal:  Front Psychol       Date:  2015-02-25

10.  Clinical laboratory tests and five-year incidence of major depressive disorder: a prospective cohort study of 433,890 participants from the UK Biobank.

Authors:  Michael Wainberg; Stefan Kloiber; Breno Diniz; Roger S McIntyre; Daniel Felsky; Shreejoy J Tripathy
Journal:  Transl Psychiatry       Date:  2021-07-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.